Details for Patent: 4,816,456

Summary for Patent: 4,816,456

Title:	Administration of monoamine acridines in cholinergic neuronal deficit states
Abstract:	A method for treating central nervous system or peripheral nervous system cholinergic deficit states such as Alzheimer's disease in a mammal, said method comprising administering to said mammal an amount of a monoamine acridine derivative effective in the treatment of a cholinergic deficit state and for a time sufficient to achieve a suitable blood level to treat said cholinergic deficit state. The preferred monoamine acridine derivative is 1,2,3,4-tetrahydro-5-aminoacridine. A unit dosage pharmaceutical composition of matter comprising an effective amount of said monoamine acridine derivative sufficient to treat said cholinergic deficit state and a pharmaceutically acceptable inert carrier therefor is also disclosed.
Inventor(s):	Summers; William K. (Arcadia, CA)
Assignee:
Application Number:	07/098,871
Patent Claim Types: see list of patent claims	Use; Delivery; Composition; Compound; Dosage form;

Drugs Protected by US Patent 4,816,456

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate

International Family Members for US Patent 4,816,456

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0328535		96C0021	Belgium
Austria	106245
Australia	621035